Company Filing History:
Years Active: 2000-2005
Title: Jörn Görlach: Innovator in Epothilone Biosynthesis
Introduction
Jörn Görlach is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of biotechnology, particularly in the biosynthesis of epothilones, which are crucial for cancer treatment.
Latest Patents
Görlach holds 2 patents related to the biosynthesis of epothilones. His latest patents involve the isolation of nucleic acid molecules from Sorangium cellulosum that encode polypeptides necessary for the production of epothilone. These patents disclose methods for producing epothilone in recombinant hosts transformed with the genes of the invention. This innovative approach allows for the production of epothilone in quantities sufficient for purification and use in pharmaceutical formulations aimed at treating cancer.
Career Highlights
Jörn Görlach is currently associated with Novartis AG, a leading global healthcare company. His work focuses on advancing biotechnological methods that enhance the production of vital pharmaceutical compounds.
Collaborations
Throughout his career, Görlach has collaborated with notable colleagues, including Thomas Schupp and James Madison Ligon. These collaborations have contributed to the advancement of research in the field of epothilone biosynthesis.
Conclusion
Jörn Görlach's innovative work in the biosynthesis of epothilones has the potential to significantly impact cancer treatment. His contributions to biotechnology exemplify the importance of research and collaboration in developing effective pharmaceutical solutions.